The Expression of Pigment Epithelium-Derived Factor in Bladder Transitional Cell Carcinoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Pigment epithelium-derived factor (PEDF) is an anti-angiogenic factor. The purpose of this study is to examine the involvement of PEDF in the angiogenesis and biological behavior of bladder transitional cell carcinoma (TCC). Methods: We examined the expression of PEDF in 99 bladder TCCs and ten non-neoplastic tissues, and evaluated microvessel density (MVD). Results: The positive immunoreactivity for PEDF was seen in normal urothelium in 60% (6/10) and TCC in 13% (13/99). The PEDF expression had a significant correlation with MVD, i.e., a low MVD in 42% (5/12), a middle MVD in 11% (8/76) and a high MVD 0% (0/11) of tumors. The PEDF expression was not significantly correlated with the differentiation and invasion of TCC, but the degree of MVD was significantly higher in both high grade TCC and the pT2 tumors. Conclusions: The degree of PEDF expression is significantly higher in normal bladder urothelium than bladder TCC; it is inversely correlated with the angiogenesis; and it is not related to the differentiation and progression of TCC. It can therefore be concluded that bladder TCC would initially occur if there is a lack of the PEDF expression.
Abstract
Background: Pigment epithelium-derived factor (PEDF) is an anti-angiogenic factor. The purpose of this study is to examine the involvement of PEDF in the angiogenesis and biological behavior of bladder transitional cell carcinoma (TCC). Methods: We examined the expression of PEDF in 99 bladder TCCs and ten non-neoplastic tissues, and evaluated microvessel density (MVD). Results: The positive immunoreactivity for PEDF was seen in normal urothelium in 60% (6/10) and TCC in 13% (13/99). The PEDF expression had a significant correlation with MVD, i.e., a low MVD in 42% (5/12), a middle MVD in 11% (8/76) and a high MVD 0% (0/11) of tumors. The PEDF expression was not significantly correlated with the differentiation and invasion of TCC, but the degree of MVD was significantly higher in both high grade TCC and the pT2 tumors. Conclusions: The degree of PEDF expression is significantly higher in normal bladder urothelium than bladder TCC; it is inversely correlated with the angiogenesis; and it is not related to the differentiation and progression of TCC. It can therefore be concluded that bladder TCC would initially occur if there is a lack of the PEDF expression.
참고문헌 (21)
- Jiménez B, "Mechanistic insights on the inhibition of tumor angiogenesis", J Mol Med (Berl), 78, pp.663~672 (2001)
- Bochner BH, "Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis", J Natl Cancer Inst, 87, pp.1603~1612 (1995)
- Teo NB, "Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast", Eur J Cancer, 39, pp.38~44 (2003)
- Tombran-Tink J, "Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells", Invest Ophthalmol Vis Sci, 30, pp.1700~1707 (1989)
- Dawson DW, "Pigment epithelium-derived factor: a potent inhibitor of angiogenesis", Science, 285, pp.245~248 (1999)
- Hase R, "Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice", Clin Cancer Res, 11(24 Pt 1), pp.8737~8744 (2005)
- Zhang L, "Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome", Int J Mol Med, 17, pp.937~944 (2006)
- Guan M, "Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor", Cancer Gene Ther, 11, pp.325~332 (2004)
- Guan M, "Adenovirus-mediated PEDF expression inhibits prostate cancer cell growth and results in augmented expression of PAI-2", Cancer Biol Ther, 6, pp.419~425 (2007)
- Feng CC, "Pigment epithelium-derived factor expression is down-regulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9", Int Urol Nephrol, 43, pp.383~390 (2011)
- Epstein JI, "The World Health Organization", International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee, 1998, pp.22, 1435~1448
- Weidner N, "Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors", Breast Cancer Res Treat, 36, pp.169~180 (1995)
- O’Reilly MS, "Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma", Cell, 79, pp.315~328 (1994)
- Good DJ, "A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin", Proc Natl Acad Sci U S A, 87, pp.6624~6628 (1990)
- O’Reilly MS, "Endostatin: an endogenous inhibitor of angiogenesis and tumor growth", Cell, 88, pp.277~285 (1997)
- Fernandez-Garcia NI, "Pigment epithelium-derived factor as a multifunctional antitumor factor", J Mol Med (Berl), 85, pp.15~22 (2007)
- Uehara H, "Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma", Cancer Res, 64, pp.3533~3537 (2004)
- Zhou D, "Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer", J Cancer Res Clin Oncol, 136, pp.1719~1727 (2010)
- Notari L, "Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia", Invest Ophthalmol Vis Sci, 46, pp.2736~2747 (2005)
- Crawford SE, "Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity", J Cell Sci, 114(Pt 24), pp.4421~4428 (2001)
- Doll JA, "Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas", Nat Med, 9, pp.774~780 (2003)